Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings. A recent survey provides key insights into patient experiences with MIBC treatment and diagnosis over the past decade. Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit. Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings. The Tandem Transplantation and Cellular Therapy Meetings offer a dedicated nursing track, networking opportunities, and more. Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee. The Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR are taking place February 12-15. Partially hydrolyzed guar gum, a soluble dietary fiber obtained from guar beans, was evaluated due to its butyrate content. The Lee Symptom Scale for skin sclerosis was informed by patient interviews and feedback. Martha Raymond, MA, founder of the GI Cancers Alliance, shares insights from her recent presentation on the programming. Study investigators say the blood-based test has the potential to improve screening rates. The questions on the quiz assess personal and family history, along with hereditary syndromes and demographics. Researchers presented data from the program during the American Society of Clinical Oncology GI Cancer Symposium. Researchers explored the real-world outcomes and management strategies in patients receiving the antibody-drug conjugate. Learn how oral dysbiosis correlates with exacerbated cGVHD in patients after receiving hematopoietic cell transplantation. Prithviraj Bose, MD, unpacks key highlights in MPN treatment and research at ASH 2024. Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research. Lisa Hwa, APRN, CNP, DNP, MS, is a member of the ASH Medical Educators Institute and has presented multiple ASH abstracts. Research presented at ASH 2024 highlighted the importance of absolute monocyte counts after transplant. Research presented at ASH 2024 showed that adding budesonide didn’t compromise immunologic recovery and transplant ...